The Protease Feed Enzyme industry trends are being reshaped by a wave of strategic activity. In early 2025, Novus Biotech partnered with AgriFeed Solutions to co‑develop a thermostable protease optimized for poultry diets, leveraging AgriFeed’s global distribution network. Meanwhile, DSM completed its acquisition of EnzyTech, expanding its portfolio of high‑efficiency enzymes for swine and aquaculture. In Q3 2024, BASF launched “ProteoMax‑G”, a genetically‑engineered protease that retains activity at pH 3.5, targeting the growing demand for low‑protein feed formulations. Regulatory momentum accelerated when the EU revised its feed additive approval pathway, shortening review times from 18 to 12 months, encouraging faster market entry. Consumer pressure for sustainable protein sources spurred a shift toward enzyme‑enhanced feed that reduces nitrogen excretion, a trend echoed in large‑scale trials in Brazil and China. Finally, Kemin secured $85 million in Series C funding to scale its enzyme‑production facility in Texas, positioning it to meet rising North‑American demand. Analysts anticipate that continued investment in precision fermentation will further lower production costs and expand application beyond traditional livestock sectors.